DaVita
Precio: 203.83Empresa y modelo de negocio
DaVita Inc. operates in the healthcare sector, primarily providing kidney care and dialysis services. The company offers a range of services including in-center hemodialysis, home dialysis, and related laboratory services. Its major business segments include dialysis services and ancillary services, with the majority of revenue generated from patient services in its dialysis centers. DaVita serves a diverse patient population across the United States and has a growing presence in international markets.
Perfil de inversión
The investment profile of DaVita is more aligned with growth investors, given its focus on expanding services and improving patient care. The company has shown potential for revenue growth despite recent fluctuations. It may appeal to investors looking for a balanced approach, considering its operational stability and market position.
Métricas fundamentales
- EPS (TTM) — ganancias por acción de los últimos 12 meses, $
- 10.15 OK
- Ingresos QoQ — crecimiento trimestral de ingresos
- -5.6% ↓
- Sorpresa EPS
- 23.2% mejor de lo esperado
- Volatilidad 20d
- 1.9% estable
Seguir en portafolio
Gráfico de precio
| Fecha | Antes | Después | Razón |
|---|---|---|---|
| 2026-06-10 00:47 | Mantener | Comprar | Strong momentum and positive EPS surprise support growth outlook. |
| 2026-06-01 02:36 | Comprar | Mantener | Strong momentum but recent revenue decline raises concerns. |
| 2026-05-16 02:40 | Mantener | Comprar | Strong momentum and positive EPS surprise support bullish outlook. |
| Fecha | Analista | Acción | Objetivo | Precio entonces |
|---|---|---|---|---|
| 2026-05-08 11:56 | Truist Financial | Objetivo aumentado | 158 → 205 | 194.385 |
| 2026-05-07 09:46 | Barclays | Objetivo aumentado | 158 → 194 | 193.88 |
| 2026-05-06 08:37 | Deutsche Bank | Rating mejorado | — → 220 | 157.04 |